Market revenue in 2022 | USD 2,148.3 million |
Market revenue in 2030 | USD 3,874.2 million |
Growth rate | 7.6% (CAGR from 2022 to 2030) |
Largest segment | Testing strips |
Fastest growing segment | Blood Glucose Meter |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Blood Glucose Meter, Testing Strips |
Key market players worldwide | Thermo Fisher Scientific Inc, Abbott Laboratories, Medtronic PLC, Roche Holding AG ADR, PHC Holdings Corp, DexCom Inc, Sanofi SA, Novo Nordisk A/S ADR, Insulet Corp, Ypsomed Holding AG, GlySens |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to self monitoring blood glucose devices market will help companies and investors design strategic landscapes.
Testing strips was the largest segment with a revenue share of 58.33% in 2022. Horizon Databook has segmented the North America self monitoring blood glucose devices market based on blood glucose meter, testing strips covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America self monitoring blood glucose devices market , including forecasts for subscribers. This continent databook contains high-level insights into North America self monitoring blood glucose devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account